FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007365323> ?p ?o ?g. }

• W2007365323 endingPage "173" @default.
• W2007365323 startingPage "169" @default.
• W2007365323 abstract "Abstract Cyclooxygenases (COX) are key enzymes in the conversion of arachidonic acid to prostaglandins. Several studies have shown a relation between angiogenesis and COX‐2 expression. Elevated expression of cyclooxygenase‐2 (COX‐2), however, has not been reported in multiple myeloma (MM) in the literature. The aim of this study is to investigate COX‐2 expression in MM as well as its correlation with prognostic factors and estimated survival rates. Immunohistochemical staining of the paraffin‐embedded bone marrow biopsy tissues ( n = 51) was performed using isoform‐specific COX‐2 polyclonal antisera (Santa Cruz Biotechnology, Santa Cruz, CA). Results were correlated with recognized clinical parameters, which were retrospectively obtained from patients' files. There were 15, 19, and 17 bone marrow biopsy specimens with negative, weak–moderate, and strong COX‐2 immunostaining, respectively. According to univariate analysis, β2‐microglobulin, age, stage, COX‐2 expression, and serum lactate dehydrogenase levels were significant prognostic factors for survival in patients with multiple myeloma. COX‐2 expression, age, and serum lactate dehydrogenase levels (greater than 1× normal level) were significant prognostic factors by multivariate analysis. Kaplan–Meier overall survival estimate of those patients with negative or weak–moderate COX‐2 immunoreactivity in myeloma cells was significantly better than that of patients with strong COX‐2 immunoreactivity (log‐rank χ 2 = 21,43, P < 0.001). COX‐2 overexpression was associated with reduced estimated survival. Poor prognostic factors such as LDH, age, and β2‐microglobulin were also correlated with COX‐2 expression. Potent, specific COX‐2 inhibitors showing evident antiangiogenic and antitumor effects on cancers could provide new therapeutic strategies in the treatment of MM. Am. J. Hematol. 80:169–173, 2005. © 2005 Wiley‐Liss, Inc." @default.
• W2007365323 created "2016-06-24" @default.
• W2007365323 creator A5001020870 @default.
• W2007365323 creator A5002981943 @default.
• W2007365323 creator A5006863054 @default.
• W2007365323 creator A5026643891 @default.
• W2007365323 creator A5033913294 @default.
• W2007365323 creator A5036762565 @default.
• W2007365323 creator A5045696675 @default.
• W2007365323 creator A5047015636 @default.
• W2007365323 creator A5056007441 @default.
• W2007365323 creator A5056050679 @default.
• W2007365323 creator A5059854078 @default.
• W2007365323 creator A5059935687 @default.
• W2007365323 creator A5067015771 @default.
• W2007365323 date "2005-10-24" @default.
• W2007365323 modified "2023-10-18" @default.
• W2007365323 title "Overexpression of cyclooxygenase‐2 in multiple myeloma: Association with reduced survival" @default.
• W2007365323 cites W1484675482 @default.
• W2007365323 cites W1569016295 @default.
• W2007365323 cites W1580444052 @default.
• W2007365323 cites W1978139448 @default.
• W2007365323 cites W1982034975 @default.
• W2007365323 cites W1988605844 @default.
• W2007365323 cites W2022715365 @default.
• W2007365323 cites W2023040133 @default.
• W2007365323 cites W2032754552 @default.
• W2007365323 cites W2034170721 @default.
• W2007365323 cites W2050310941 @default.
• W2007365323 cites W2058118671 @default.
• W2007365323 cites W2067379331 @default.
• W2007365323 cites W2079555075 @default.
• W2007365323 cites W2101307567 @default.
• W2007365323 cites W2123274778 @default.
• W2007365323 cites W2127558096 @default.
• W2007365323 cites W2132919130 @default.
• W2007365323 cites W2151324279 @default.
• W2007365323 cites W2319962899 @default.
• W2007365323 cites W2324677651 @default.
• W2007365323 cites W2999700545 @default.
• W2007365323 cites W4237139322 @default.
• W2007365323 doi "https://doi.org/10.1002/ajh.20460" @default.
• W2007365323 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16247750" @default.
• W2007365323 hasPublicationYear "2005" @default.
• W2007365323 type Work @default.
• W2007365323 sameAs 2007365323 @default.
• W2007365323 citedByCount "27" @default.
• W2007365323 countsByYear W20073653232012 @default.
• W2007365323 countsByYear W20073653232014 @default.
• W2007365323 countsByYear W20073653232015 @default.
• W2007365323 countsByYear W20073653232016 @default.
• W2007365323 countsByYear W20073653232017 @default.
• W2007365323 countsByYear W20073653232019 @default.
• W2007365323 countsByYear W20073653232021 @default.
• W2007365323 countsByYear W20073653232023 @default.
• W2007365323 crossrefType "journal-article" @default.
• W2007365323 hasAuthorship W2007365323A5001020870 @default.
• W2007365323 hasAuthorship W2007365323A5002981943 @default.
• W2007365323 hasAuthorship W2007365323A5006863054 @default.
• W2007365323 hasAuthorship W2007365323A5026643891 @default.
• W2007365323 hasAuthorship W2007365323A5033913294 @default.
• W2007365323 hasAuthorship W2007365323A5036762565 @default.
• W2007365323 hasAuthorship W2007365323A5045696675 @default.
• W2007365323 hasAuthorship W2007365323A5047015636 @default.
• W2007365323 hasAuthorship W2007365323A5056007441 @default.
• W2007365323 hasAuthorship W2007365323A5056050679 @default.
• W2007365323 hasAuthorship W2007365323A5059854078 @default.
• W2007365323 hasAuthorship W2007365323A5059935687 @default.
• W2007365323 hasAuthorship W2007365323A5067015771 @default.
• W2007365323 hasBestOaLocation W20073653231 @default.
• W2007365323 hasConcept C10515644 @default.
• W2007365323 hasConcept C126322002 @default.
• W2007365323 hasConcept C142724271 @default.
• W2007365323 hasConcept C143998085 @default.
• W2007365323 hasConcept C181199279 @default.
• W2007365323 hasConcept C204232928 @default.
• W2007365323 hasConcept C21957315 @default.
• W2007365323 hasConcept C2776364478 @default.
• W2007365323 hasConcept C2777318727 @default.
• W2007365323 hasConcept C2779689624 @default.
• W2007365323 hasConcept C2780007613 @default.
• W2007365323 hasConcept C4224716 @default.
• W2007365323 hasConcept C50382708 @default.
• W2007365323 hasConcept C55493867 @default.
• W2007365323 hasConcept C71924100 @default.
• W2007365323 hasConcept C86803240 @default.
• W2007365323 hasConcept C90924648 @default.
• W2007365323 hasConceptScore W2007365323C10515644 @default.
• W2007365323 hasConceptScore W2007365323C126322002 @default.
• W2007365323 hasConceptScore W2007365323C142724271 @default.
• W2007365323 hasConceptScore W2007365323C143998085 @default.
• W2007365323 hasConceptScore W2007365323C181199279 @default.
• W2007365323 hasConceptScore W2007365323C204232928 @default.
• W2007365323 hasConceptScore W2007365323C21957315 @default.
• W2007365323 hasConceptScore W2007365323C2776364478 @default.
• W2007365323 hasConceptScore W2007365323C2777318727 @default.
• W2007365323 hasConceptScore W2007365323C2779689624 @default.
• W2007365323 hasConceptScore W2007365323C2780007613 @default.

• next